Drug Repurposing Central is an innovative Open Science publishing portal designed to advance the field of drug repurposing. Developed under the REPO4EU Horizon Europe project, this platform features a comprehensive suite of tools and resources to support the dissemination of research, including a dedicated preprint server (DrugRxiv), two diamond open access journals ( Drug Repurposing and Network Medicine ), and an interactive research collection. By integrating open peer review, persistent identifiers, machine-readable open licenses, and alternative metrics, Drug Repurposing Central enhances transparency, reproducibility, and accessibility. This portal addresses the balance between Open Science and intellectual property protection, ensuring that research outputs are both openly accessible and potentially patentable. As a beacon of Open Science, Drug Repurposing Central aims to foster collaboration, increase research impact, and drive the development of new treatments, contributing to the global effort to improve healthcare outcomes.
No takes yet. Share an insight, caveat, or question.
Stephanie Dawson (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: